A New Approach to Treating Alzheimer's Disease Receives Major ...
RESEARCH TRIANGLE PARK, North Carolina, May 20, 2019 /PRNewswire-AsiaNet/ -- - T3D Therapeutics to Receive $9 Million Multiyear National Institute on Aging Grant for Phase 2 PIONEER Study in Mild-to-Moderate Alzheimer's Disease PatientsT3D Therapeutics, a clinical stage drug development company engaged in the developme...
Authors: LATEST ASIANET NEWS RELEASES